Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSinclair Pharma Share News (SPH)

  • There is currently no data for SPH

TechMARK movers: Restructuring costs hit Sinclair figures

Thu, 25th Feb 2010 14:36
Sinclair Pharma shares fell after it reported a slump into loss in 2009 but much of that was due to restructuring costs. However, another large loss is expected this year. New chief executive Chris Spooner has wasted little time in restructuring the business and boosting the sales expertise in the group. He ended Sinclair's distribution agreement with Orapharma Inc for Decapinol mouth rinse and plans to find another partner covering more of the market.Sinclair has negotiated new debt facilities of £9m and raised £18.2m from a share placing. The cash was used to finance the acquisition of Flammazine and Flammacerium (used for topical treatment of burns) from Solvay Pharmaceuticals for £16.8m. Sinclair had net debt of £12.3m at the end of 2009.Revenues were one-third lower than last year at £11m. Stripping out one-off payments, underlying revenues were 1% lower. Sinclair made a profit of £3.17m in 2008 but that was down to foreign exchange gains. The 2009 loss was £14.5m and around two-thirds of this was due to impairment charges and restructuring costs. Broker Singer has increased its forecast loss for 2010 from £6.1m to £15m. Stripping out exceptional charges the forecast loss rises from £1.7m to £2m. Singer has a 41p a share price target and says it believes that "the company is now better placed to deliver long term financial growth". Shares in IT services provider Logica are recovering following yesterday's fall on the announcement of figures for 2009. Revenues are expected to fall in the first half of 2010 and be flat for the year as a whole. FTSE TechMARK - RisersVisonic (VSC) 82.00p +2.50%Psion (PON) 92.00p +2.22%Ark Therapeutics (AKT) 14.50p +1.75%NXT (NTX) 14.75p +1.72%BT Group (BT.A) 117.60p +1.29%Intec Telecom Systems (ITL) 98.00p +1.29%COLT Telecom Group S.A. (COLT) 136.50p +1.11%Logica (LOG) 118.20p +1.11%Vodafone Group (VOD) 142.20p +0.85%Anite Group (AIE) 32.50p +0.78%FTSE TechMARK - FallersRenovo Group (RNVO) 27.25p -6.03%Sinclair Pharma (SPH) 29.50p -4.84%Oxford Instruments (OXIG) 232.00p -4.13%Gresham Computing (GHT) 19.00p -3.80%Vernalis (VER) 73.50p -3.61%Morse (MOR) 40.00p -2.44%Phoenix IT Group (PNX) 275.00p -2.22%Innovation Group (TIG) 12.50p -1.96%XP Power (XPP) 425.00p -1.96%Consort Medical (CSRT) 356.00p -1.79%

Related News

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)
23 Oct 2018

GLG Partners Doubles Sinclair Pharma Stake To 10.8% From 5.1% (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Tuesday that GLG Partners LP doubled its stake in the company to 10.81%.GLG's previous holding in th...

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)
19 Oct 2018

Toscafund Asset Management Divests Entire Sinclair Pharma Holding (ALLISS)

LONDON (Alliance News) - Sinclair Pharma PLC said Friday that Toscafund Asset Management LLP divested its entire stake in the company.Prior to selling...

Sinclair Pharma News

Sinclair IS Pharma buys global rights to dermal gel Perfectha
7 Jan 2014

Sinclair IS Pharma buys global rights to dermal gel Perfectha

Jan 7 (Reuters) - Sinclair IS Pharma Plc said it entered an agreement to buy the global rights to dermal gel brand Perfectha, in a deal that is expect...

Broker tips: Asos, Sinclair, Booker
19 Sep 2013

Broker tips: Asos, Sinclair, Booker

Online fashion retailer Asos impressed investors on Thursday as it beat fourth quarter forecasts to wrap up the year in style. The AIM-listed company...

Broker snap: Jefferies on Sinclair IS Pharma's full-year results
19 Sep 2013

Broker snap: Jefferies on Sinclair IS Pharma's full-year results

Sinclair IS Pharma was issued a 'buy' rating by Jefferies International after reporting a jump in pre-tax profit for the full year 2013. Adjusted pro...

Sinclair Pharma in-line full year results thanks to uplift in facials
19 Sep 2013

Sinclair Pharma in-line full year results thanks to uplift in facials

Profits shot up at dermatology focused drug company Sinclair IS Pharma thanks to strong growth of its aesthetic non-surgical facelift products. Adju...

Thursday broker round-up UPDATE
19 Sep 2013

Thursday broker round-up UPDATE

ASOS: Canaccord Genuity increases target price from 3400p to 6200p and upgrades to buy. Associated British Foods: Jefferies raises target price from ...